CAN
ESPR

Cetera Advisor Networks’s Esperion Therapeutics ESPR Stock Holding History

Cetera Advisor Networks’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$33.5K Hold
12,500
– – ﹤0.01% 2766
2023
Q4 		$37.4K Sell
12,500
-762
-6% -$988 ﹤0.01% 2720
2023
Q3 		$13K Hold
13,262
– – ﹤0.01% 2681
2023
Q2 		$18.4K Buy
13,262
+337
+3% +$471 ﹤0.01% 2558
2023
Q1 		$20.6K Hold
12,925
– – ﹤0.01% 2533
2022
Q4 		$80.5K Hold
12,925
– – ﹤0.01% 2399
2022
Q3 		$87K Hold
12,925
– – ﹤0.01% 1978
2022
Q2 		$82K Hold
12,925
– – ﹤0.01% 1974
2022
Q1 		$60K Hold
12,925
– – ﹤0.01% 2009
2021
Q4 		$65K Sell
12,925
-100
-0.8% -$801 ﹤0.01% 1992
2021
Q3 		$157K Buy
13,025
+2,975
+30% +$43.3K ﹤0.01% 1846
2021
Q2 		$213K Buy
10,050
+75
+0.8% +$1.81K ﹤0.01% 1729
2021
Q1 		$280K Sell
9,975
-375
-4% -$11.1K 0.01% 1182
2020
Q4 		$269K Sell
10,350
-500
-5% -$15K 0.01% 1104
2020
Q3 		$403K Sell
10,850
-1,150
-10% -$45.5K 0.01% 795
2020
Q2 		$616K Buy
12,000
+4,753
+66% +$199K 0.02% 610
2020
Q1 		$228K Buy
7,247
+3,845
+113% +$203K 0.01% 932
2019
Q4 		$203K Buy
+3,402
New +$153K 0.01% 1150

Other funds holding ESPR

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Cetera Advisor Networks's ESPR Position: Q1 2024 in Review

Cetera Advisor Networks held its Esperion Therapeutics (ESPR) position steady in Q1 2024 at 12,500 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2766.

Cetera Advisor Networks first reported a position in ESPR in Q4 2019 and has held it in 18 quarters since. The position peaked at $616K in Q2 2020. 153 funds tracked by Wall St. Rank hold ESPR as of Q1 2024.

  • Cetera Advisor Networks held 12,500 shares of Esperion Therapeutics worth $33.5K as of Q1 2024.
  • Cetera Advisor Networks left its Esperion Therapeutics share count unchanged in Q1 2024.
  • Esperion Therapeutics made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2766 holding.
  • Cetera Advisor Networks first reported a position in Esperion Therapeutics in Q4 2019 and has held it in 18 quarters since.
  • Cetera Advisor Networks's Esperion Therapeutics position peaked at $616K in Q2 2020.
  • 153 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.